LCN2 and kidney disorder: Our study aimed to determine the prevalence of kidney disease and associated factors among adults with chronic HBV using a combination of kidney function biomarkers including a novel biomarker, urine NGAL, in a cohort of adults with chronic HBV in southwestern Uganda.